Research Reports
Every report we've published, newest first.
EVTV: The Electric Vehicle Stock That Broke Bad and Went Full AI — Tape Read
Mar 18, 2026EVTV's 46% rip on 8.3M volume tells the story of a desperation pivot gone right, but dilution demons still lurk in the shadows.
Read → ARTLARTL Pops 33% on Glaucoma Study Deal, But Don't Ignore the Warning Signs
Mar 18, 2026ARTL exploded 33% on glaucoma study news with 72x float volume, but the cash burn and dilution risks make this more squeeze than substance.
Read → VNRXVNRX Pops 39% on "World-First" Liquid Biopsy Breakthrough Amid Delisting Risks
Mar 18, 2026VNRX explodes 39% on breakthrough liquid biopsy claims, but massive volume and delisting pressures create a complex risk-reward setup.
Read → LBGJLBGJ: The Anatomy of a 138% Pre-Market Pump — And Why It's Already Unwinding
Mar 18, 2026LBGJ rockets 138% in pre-market but immediately begins fading from highs, exposing the mechanical nature of the move and underlying dilution risks.
Read → AIMAIM ImmunoTech (AIM) Explodes 110% Pre-Market After Japan Patent Win Triggers Fresh Catalyst
Mar 18, 2026AIM explodes 110% pre-market after securing final Japanese patent approval for Ampligen cancer combination therapy, but dilution risks loom from recent rights offering.
Read → BIAFBIAF's Wild March Ride: The Rise, the Hype, and the Reality Check
Mar 17, 2026bioAffinity Technologies exploded 122% on March 13 earnings, then gave back gains as investors parsed the dilution-heavy reality behind the revenue surge.
Read → UCARUCAR Explodes 67% Pre-Market: Thailand Truck Deal Sparks Skepticism and Opportunity
Mar 17, 2026UCAR explodes 67% pre-market on Thailand battery-truck news, but the skeptic's math reveals dilution risks that bulls are ignoring in this micro-cap momentum play.
Read → LNAILNAI: When The Float Breaks — Anatomy of a 160% Pre-Market Spike Gone Wrong
Mar 17, 2026LNAI exploded 160% pre-market Monday on classic squeeze mechanics, but this dying biotech's final spike before potential delisting represents everything dangerous about small-cap trading.
Read → WNWWNW Stock Rockets 570% on AI Initiative, But Dilution Risk Looms Large
Mar 16, 2026Meiwu Technology's shares exploded from $1.80 to $13.52 after announcing an AI-powered skincare R&D program, but recent dilution and pending shelf offerings cloud the momentum play.
Read → ABCDABCD Pre-Market Momentum: The Filing Nobody's Talking About
Mar 14, 2026ABCD ripped 18% pre-market on volume that doesn't match anything in the last 30 days. No PR. No earnings. So what moved it?
Read → EFGHEFGH Postmortem: How a 424B5 Filing Turned a 40% Runner Into a Trap
Mar 13, 2026EFGH ran 40% in the first hour yesterday. By close, it was red. Here's what the filing told you at 7 AM that most people didn't read until it was too late.
Read → IJKLIJKL: FDA Catalyst, Tight Float, and a Setup That Actually Looks Interesting
Mar 12, 2026Most small-cap FDA plays are lottery tickets. IJKL might actually have the structure to hold a move — if you understand the float dynamics.
Read →